EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting BRD2 and BRD4 inhibit the growth of KSHV-infected immortalized endothelial cells through suppression of LANA translation

Jungang Chen, Jiaojiao Fan, Margaret Qin, Zhen Lin, Shengyu Mu, Lu Dai, Zhiqiang Qin iD

PLOS Pathogens · 01.06.2026 · 22 (6) · e1014288

DOI: 10.1371/journal.ppat.1014288 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 01.06.2026. Verfasst von Jungang Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States …. Hauptthemen laut MEDLINE: Transcription Factors, Herpesvirus 8, Human, Nuclear Proteins, Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kaposi’s sarcoma-associated herpesvirus (KSHV) is the etiologic agent of several human cancers, including Kaposi’s sarcoma (KS) and primary effusion lymphoma (PEL), both of which still lack effective treatment options. Members of the bromodomain and extra-terminal domain (BET) family, especially bromodomain-containing protein 4 (BRD4), play important roles in RNA polymerase II–mediated transcriptional regulation and are required for the expression of many tumor-driving oncogenes in various cancer cells. Therefore, BET proteins have become attractive targets for anticancer drug development. Previous studies have demonstrated the high sensitivity of PEL cells to BET inhibitors, and BRD4 silencing effectively blocks tumor cell proliferation. In contrast, KSHV-infected immortalized endothelial cells display strong resistance to BET inhibitors, including (+)-JQ1. To further develop BRD-targeted therapies for KSHV-infected immortalized endothelial cells, we identified MZ-1 and SIM-1, two BRD4 PROTAC degraders, as effective inhibitors of cell growth in these cells. Mechanistically, these inhibitory effects depend on suppression of LANA translation through increased eIF2α phosphorylation in KSHV-infected cells. Similar LANA suppression was also observed following RNAi-mediated silencing of BRD2 or BRD4. Proteomic analysis identified unique protein candidates altered in MZ-1- and SIM-1-treated KSHV-infected immortalized endothelial cells compared with (+)-JQ1-treated cells. In summary, our study develops an effective strategy against KSHV-infected immortalized endothelial cells using selective BRD PROTACs, which may help improve therapeutic outcomes for KSHV-related malignancies in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcription FactorsHerpesvirus 8, HumanNuclear ProteinsProtein Serine-Threonine KinasesEndothelial CellsSarcoma, KaposiHumansBromodomain Containing ProteinsCell Cycle ProteinsCell ProliferationProtein BiosynthesisProteolysis Targeting ChimeraAntigens, Viral

Substanzen

Bromodomain Containing ProteinsBRD4 protein, humanTranscription FactorsCell Cycle ProteinsNuclear ProteinsProtein Serine-Threonine Kinaseslatency-associated nuclear antigenBRD2 protein, humanProteolysis Targeting ChimeraAntigens, Viral

Autor:innen und Institutionen

  • Department of Pathology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America.
  • Little Rock Central High School, Little Rock, Arkansas, United States of America.
  • Department of Pathology, Tulane University Health Sciences Center, Tulane Cancer Center, New Orleans, Louisiana, United States of America.
  • Department of Pharmacology & Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America.

ORCID-Profile: Zhiqiang Qin

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
  • National Cancer Institute
  • National Institute of General Medical Sciences
  • National Heart, Lung, and Blood Institute
  • American Heart Association

Zitieren

APA

Chen, J., Fan, J., Qin, M., Lin, Z., Mu, S., Dai, L., & Qin, Z. (2026). Targeting BRD2 and BRD4 inhibit the growth of KSHV-infected immortalized endothelial cells through suppression of LANA translation. PLOS Pathogens, 22(6), e1014288. https://doi.org/10.1371/journal.ppat.1014288

Vancouver

Chen J, Fan J, Qin M, Lin Z, Mu S, Dai L, et al. Targeting BRD2 and BRD4 inhibit the growth of KSHV-infected immortalized endothelial cells through suppression of LANA translation. PLOS Pathogens. 2026;22(6):e1014288. doi:10.1371/journal.ppat.1014288

BibTeX
@article{Chen2026,
  author = {Chen, Jungang and Fan, Jiaojiao and Qin, Margaret and Lin, Zhen and Mu, Shengyu and Dai, Lu and Qin, Zhiqiang},
  title = {Targeting BRD2 and BRD4 inhibit the growth of KSHV-infected immortalized endothelial cells through suppression of LANA translation},
  journal = {PLOS Pathogens},
  year = {2026},
  volume = {22},
  number = {6},
  pages = {e1014288},
  doi = {10.1371/journal.ppat.1014288}
}
Kostenlos starten →